Find Us on Facebook Follow Us on Twitter Find Us on Youtube Bookmark & Share Subscribe to Feed

Cancer Research: Antioxidant diet and genotyping as tools for the prevention of liver disease.



Related Articles

Antioxidant diet and genotyping as tools for the prevention of liver disease.

Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5155-5163

Authors: Di Francia R, Rinaldi L, Cillo M, Varriale E, Facchini G, D’Aniello C, Marotta G, Berretta M

Abstract
It is well-known that 75% of risk factors of chronic liver disease (CLD) are related to nutrition. These circumstances potentially progress towards liver steatosis, fibrosis and hepatocellular carcinoma (HCC). It still represents an enormous problem for the economy of public health worldwide. Furthermore, validated prevention programs could be the solution. Recent knowledge in understanding molecular determinants of energy liver metabolism and new genetic markers offers new insights into the pathogenesis of CLD and HCC. The main rationale of the present issue is to provide a summary of recent insights into the inherited variants regulating lipid metabolism (steatohepatitis) and acquired mutation for early diagnosis of HCC, specifically focusing on the significance of antioxidant agents and genotyping tests as a cost-effectiveness tool for the prevention of liver disease. Several national healthy programs worldwide promote the daily use of antioxidant nutrients either for the prevention and/or as complementary and alternative medicines (CAM). This review could be advising for the planning of a large-scale clinical trial including a combination strategy of antioxidant agents and genotyping tests in patients with high risk of CLD.

PMID: 28051253 [PubMed – indexed for MEDLINE]

pubmed: cancer complementary…

Cancer News: AstraZeneca cancer drug trial prompts investors to take options cover


LONDON/NEW YORK (Reuters) – Investors in drugmaker AstraZeneca have taken defensive positions in the options market ahead of eagerly awaited results of a major trial of a lung cancer treatment, which are due any day now.


Reuters: Health News

Cancer News: California to list glyphosate as cancer-causing; Monsanto vows fight


(Reuters) – Glyphosate, an herbicide and the active ingredient in Monsanto Co’s popular Roundup weed killer, will be added to California’s list of chemicals known to cause cancer effective July 7, the state’s Office of Environmental Health Hazard Assessment (OEHHA) said on Monday.


Reuters: Health News

Cancer News: Medicaid cuts linked to later breast cancer diagnosis


(Reuters Health) – More women may be diagnosed with advanced breast cancer and suffer treatment delays when Medicaid cutbacks eliminate coverage for many adults with low-income jobs, a study in Tennessee suggests.


Reuters: Health News

Cancer News: Novartis breast cancer drug Kisqali wins European panel backing


ZURICH (Reuters) – A European Medicines Agency (EMA) panel recommended on Friday approving Novartis’s Kisqali drug, bolstering the Swiss drugmaker’s bid to challenge rival Pfizer’s Ibrance against tough-to-treat breast cancer.


Reuters: Health News